Contraception

Article	Citations
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond	112
The impact of the COVID-19 pandemic on economic security and pregnancy intentions among people at risk of pregnancy	82
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic	63
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters	55
Development of the Person-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning care scale	53
The association between state-level abortion restrictions and maternal mortality in the United States, 1995-2017	47
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone	47
Telemedicine for contraceptive counseling: An exploratory survey of US family planning providers following rapid adoption of services during the COVID-19 pandemic	45
COVID-19’s impact on contraception experiences: Exacerbation of structural inequities in women's health	41
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results	37
Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: A retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador	36
Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth	34
Telemedicine for contraceptive counseling: Patient experiences during the early phase of the COVID-19 pandemic in New York City	33
Changes to medication abortion clinical practices in response to the COVID-19 pandemic	32
Declines in contraceptive visits in the United States during the COVID-19 pandemic	32
Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks’ gestation at British Pregnancy Advisory Service: A cross-sectional evaluati	27
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64–70 days and 71–77 days of gestation	27
“It was close enough, but it wasn't close enough”: A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care	26
Exploring the reproductive decision support needs and preferences of women with cystic fibrosis,	24
Abortion method preference among people presenting for abortion care	24
Patient and pharmacist perspectives on pharmacist-prescribed contraception: A systematic review	23
“$231 … to pull a string!!!” American IUD users’ reasons for IUD self-removal: An analysis of internet forums	23
Provision of medication abortion in Hawai‘i during COVID-19: Practical experience with multiple care delivery models	23
Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry	22
Doctor knows best? Provider bias in the context of contraceptive counseling in the United States	22

The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization	21
Racial and ethnic differences in family planning telehealth use during the onset of the COVID-19 response in Arkansas, Kansas, Missouri, and Oklahoma	20
Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20–24 weeks’ gestation	19
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S	19
Differences in abortion rates by race–ethnicity after implementation of a restrictive Texas law	19
Barriers to abortion care and incidence of attempted self-managed abortion among individuals searching Google for abortion care: A national prospective study	18
Reasons for and experience in obtaining pharmacist prescribed contraception	18
Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic	18
Characterizing community-level abortion stigma in the United States	17
Use of nonpreferred contraceptive methods among women in Ohio	17
Trends in medication abortion provision before and after the introduction of mifepristone: A study of the National Abortion Federation’s Canadian member services	16
Improving contraceptive use among Latina adolescents: A cluster-randomized controlled trial evaluating an mHealth application, Health-E You/Salud iTu	16
Exploring providers’ experience of stigma following the introduction of more liberal abortion care in the Republic of Ireland	16
Self-removal of long-acting reversible contraception: A content analysis of YouTube videos	15
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world	15
Birth Control Connect: A randomized trial of an online group to disseminate contraceptive information	15
Women's knowledge of their state's abortion regulations. A national survey	15
Complication rates of dilation and evacuation and labor induction in second-trimester abortion for fetal indications: A retrospective cohort study	15
Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals	15
Twenty Years of the Ryan Residency Training Program in Abortion and Family Planning	15
Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results	15
Effects of clinic-level implementation of One Key Question® on reproductive health counseling and patient satisfaction	15
Medication Abortion Up to 70 Days of Gestation	15
Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women	14
Family medicine provision of online medication abortion in three US states during COVID-19	14
US clinicians’ perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care	14
“It’s a very nuanced discussion with every woman”: Health care providers’ communication practices during contraceptive counseling for patients with substance use disorders	14
Society of Family Planning committee consensus on Rh testing in early pregnancy	14
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype	14
An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)	14
Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response	14
COVID-19 highlights the policy barriers and complexities of postpartum sterilization	13
The mifepristone REMS: A needless and unlawful barrier to care✰	13
“It gives you autonomy over your own choices”: A qualitative study of Canadian abortion patients’ experiences with mifepristone and misoprostol	13
The effects of CenteringPregnancy group prenatal care on postpartum visit attendance and contraception use	13
Hormonal contraceptive use in Ghana: The role of method attributes and side effects in method choice and continuation	13
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials	13
Working in the shadows, under the spotlight – Reflections on lessons learnt in the Republic of Ireland after the first 18 months of more liberal Abortion Care	13
Socioeconomic differences persist in use of permanent vs long-acting reversible contraception: An analysis of the National Survey of Family Growth, 2006 to 2010 vs 2015 to 2017	13
Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function	13
Timing of pregnancy discovery among women seeking abortion,	13
Border-state abortions increased for Texas residents after House Bill 2	12
Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phase	12
Exploring the emotional costs of abortion travel in the United States due to legal restriction	12
Effect of levonorgestrel emergency contraception on implantation and fertility: A review	12
Recommendations for standardization of bleeding data analyses in contraceptive studies	12
Abortion on American television: An update on recent portrayals, 2015–2019	12
Association of the affordable care act Medicaid expansions with postpartum contraceptive use and early postpartum pregnancy	12
Difficult etonogestrel implant removals in South Africa: A review of 74 referred cases	12
Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion	12

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France	11
Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan	11
Complex family Planning: A newly accredited, landmark fellowship	11
Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois	11
The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review	11
Attitudes of US adults toward using telemedicine to prescribe medication abortion during COVID-19: A mixed methods study	11
A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64–70 and 71–77 days of gestation: A retrospective chart review	11
Balancing enhanced contraceptive access with risk of reproductive injustice: A United States comparative case study	11
Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰	11
Contraceptive method type and satisfaction, confidence in use, and switching intentions	11
Higher contraceptive uptake in HIV treatment centers offering integrated family planning services: A national survey in Kenya	11
Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India	11
Adolescent emergency contraception usage, knowledge, and perception	11
“Becoming the woman she wishes you to be”: A qualitative study exploring the experiences of medication abortion acompañantes in three regions in Mexico	11
Home pregnancy test use and timing of pregnancy confirmation among people seeking health care	11
Ethinyl estradiol vs estradiol valerate in combined oral contraceptives – Effect on glucose tolerance: A randomized, controlled clinical trial	11
Health workers’ values and preferences regarding contraceptive methods globally: A systematic review	10
Introduction of telemedicine for medication abortion: Changes in service delivery patterns in two U.S. states	10
Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont	10
Oral contraceptive generations – Time to stop using a marketing myth to define nomenclature	10
Perceptions and practice of state Medicaid officials regarding informed consent for female sterilization	10
Physician attitudes about abortion and their willingness to consult in abortion care at a Midwestern academic medical center	10
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system	10
Contraception decision-making and care among reproductive-aged women with autoimmune diseases	10
Online community queries on hormonal male contraception: An analysis of the Reddit “Ask Me Anything” experience	10
Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon	10
Contraceptive use and preferences among females with sickle cell disease	9
Exploring potential interest in missed period pills in two US states	9
Attitudes and beliefs of obstetricians–gynecologists regarding Medicaid postpartum sterilization – A qualitative study	9
The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg	9
Society of Family Planning clinical recommendations: Pain control in surgical abortion part 2 – Moderate sedation, deep sedation, and general anesthesia	9
Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone	9
The disproportionate burdens of the mifepristone REMS	9
A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day	9
Contraceptive use at first sexual intercourse among adolescent and young adult women with disabilities: The role of formal sex education	9
Medication abortion with misoprostol-only: A sample protocol	9
Contraceptive method denial as downward contraceptive coercion: A mixed-methods mystery client study in Western Kenya	9
Values and preferences for contraception: A global systematic review	9
Fertility intentions and recent births among US abortion patients	9
Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years	9
Contraceptive values and preferences of adolescents and young adults: A systematic review	8
Barriers accessing abortion care and their association with psychological well-being	8
Exploring the physician's role in contraceptive counseling at the time of abortion in the US	8
Society of Family Planning Clinical Recommendation: Emergency contraception	8
Postpartum contraception method type and risk of a short interpregnancy interval in a state Medicaid population	8
Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States	8
Early pregnancy care in North America: A proposal for high-value care that can level health disparities	8
Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review	8
“It prevents a fertilized egg from attaching…and causes a miscarriage of the baby”: A qualitative assessment of how people understand the mechanism of action of emergency contraceptive pills	8
Safety of deep sedation without intubation during surgical abortion in the independent clinic setting	8
Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge – A prospective cohort study in Finland	8
Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation	8
Certainty and intention in pregnancy decision-making: An exploratory study	8
Telehealth contraceptive care in 2018: A quality improvement study of barriers to access and patient satisfaction	8
“Shared risk”: Reframing risk analysis in the ethics of novel male contraceptives,	8
The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States	8
Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.	8
Exploring the experience of IUD self-removal in the United States through posts on internet forums	7
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial	7
Abortion service provision in South Asia: A comparative study of four countries	7
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries	7
Patient perspectives on barriers in obtaining timely abortion care in Los Angeles, California	7
Quantitative and qualitative impact of One Key Question on primary care providers’ contraceptive counseling at routine preventive health visits	7
State and federal abortion restrictions increase risk of COVID-19 exposure by mandating unnecessary clinic visits	7
Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy	7
Abortion restrictions in the state of Georgia: Anticipated impact on people seeking abortion	7
An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users	7
Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders	7
Contraceptive decision making among pregnancy-capable individuals with opioid use disorder at a tertiary care center in Massachusetts	7
Variation by state in Medicaid sterilization policies for physician reimbursement	7
“False positive” urine pregnancy test results after successful medication abortion	7
Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey	7
The effect of antenatal counseling and intrauterine device insertion services on postpartum contraceptive use in Nepal: Results from a stepped-wedge randomized controlled trial	7
Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project	7
“It's a horrible assignment”: A qualitative study of labor and delivery nurses’ experience caring for patients undergoing labor induction for fetal anomalies or fetal demise	7
Self-managed abortion: Exploring synergies between institutional medical systems and autonomous health movements	7
Female permanent contraception policies and occurrence at a sample of U.S. prisons and jails	7
“We're called upon to be nonjudgmental”: A qualitative exploration of United States medical students’ discussions of abortion as a reflection of their professionalism	7
Standardizing abortion research outcomes (STAR): Results from an international consensus development study	7
The experience of pain in real-time during medication abortion	7

Oral and IUD emergency contraception provision among a national sample of obstetrician–gynecologists	7
Estimating the annual domestic adoption rate and lifetime incidence of infant relinquishment in the United States,	7
The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study	7
“I just was really scared, because it's already such an uncertain time”: Exploring women's abortion experiences during the COVID-19 pandemic in Canada	7
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials	7
Withdrawal method inquiries and user experiences: An analysis of content posted on 4 gendered forums on Reddit	7
Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings	7
Factors associated with abortion at 12 or more weeks gestation after implementation of a restrictive Texas law	7
Traveling for rights: Abortion trends in New Mexico after passage of restrictive Texas legislation	6
Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study	6
US referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: A case series	6
Assessment of contraceptive use in Puerto Rico during the 2016 Zika virus outbreak	6
Provision of contraceptive implants in school-based health centers: A cost-effectiveness analysis	6
Community perspectives on pharmacist-prescribed hormonal contraception in rural California	6
Exploring crowdfunding campaigns for abortion services	6
Termination of pregnancy services in Irish general practice from January 2019 to June 2019	6
Refugee women's experiences with contraceptive care after resettlement in high-income countries: A critical interpretive synthesis	6
Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception	6
Contraception values and preferences of people living with HIV: A systematic review	6
Safety and effectiveness of medication and aspiration abortion before or during the sixth week of pregnancy: A retrospective multicenter study	6
Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss	6
Over-the-counter access to levonorgestrel emergency contraception in South Texas: Does Over-the-counter mean ready to buy?	6
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate	6
Denial of tubal ligation in religious hospitals: Consumer attitudes when insurance limits hospital choice	6
Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment	6
From training to implementation: Improving contraceptive practices in South Carolina	6
Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial	6
Incidence and characteristics of intravascular pulmonary migration of etonogestrel implants: A French nationwide study	6
Access to single-visit IUD insertion at obstetrician-gynecology practices in Ohio: An audit study	6
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women	6
Society of Family Planning clinical recommendations: Management of individuals with bleeding or thrombotic disorders undergoing abortion	6
Abortion at 12 or more weeks’ gestation and travel for later abortion care among Mississippi residents	6
Evaluation of the Delaware Contraceptive Access Now (DelCAN) initiative: A qualitative analysis of site leaders’ implementation recommendations	6
Exploring financial stress and resource deprivation as barriers to preferred contraceptive use in Wisconsin in 2021	6
Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study	6
Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations	6
Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity	6
Ovulation inhibition with a new vaginal ring containing trimegestone	6
The COVID-19 pandemic's impact on sexual and reproductive health in Georgia, USA: An exploration of behaviors, contraceptive care, and partner abuse	6
Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database	6
Patient-reported experience with discussion of all options during pregnancy options counseling in the US South	5
Sonographic findings after induced medical abortion at 12–21 weeks of gestation: Retrospective cohort study	5
Medical abortion offered in pharmacy versus clinic-based settings: A systematic review	5
Access to male sexual and reproductive health services in publicly funded California clinics in 2018	5
Pregnancy intentions and contraceptive uptake after miscarriage	5
The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease	5
“I never went to see that doctor again”: A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion	5
Timing of insertion affects expulsion in patients using the levonorgestrel 52 mg intrauterine system for noncontraceptive indications	5
Contraception information on the websites of student health centers in the United States	5
Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints	5
Addressing contraceptive needs exacerbated by COVID-19: A call for increasing choice and access to self-managed methods	5
Access to contraceptive services among Myanmar women living in Japan: A qualitative study	5
Increasing access to single-visit contraception in urban health care settings: Findings from a multi-site learning collaborative	5
Characteristics of people obtaining medication vs procedural abortions in clinical settings in the United States: Findings from the 2021–2022 Abortion Patient Survey	5
Men’s willingness to use novel male contraception is linked to gender-equitable attitudes: Results from an exploratory online survey	5
P28 Breaking down abortion barriers: Reddit users’ empowerment in absence of parental and medical support	5
Foley catheter and misoprostol for cervical preparation for second-trimester surgical abortion	5
Perceptions of long-acting reversible contraception among women in an urban U.S. jail	5
“I didn’t doubt my choice, but I felt bad”: A qualitative exploration of Canadian abortion patients’ experiences with protesters	5
Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation	5
SOCIAL SCIENCE ORAL ABSTRACTS	5
Fetal tissue donation for research at the time of abortion: A qualitative study of individuals who experienced an abortion in Hawaii in 2018-19	5
Now is the time to safeguard access to emergency contraception as abortion restrictions sweep the United States	5
Validation of the short-form reproductive coercion scale with Appalachian women	5
Exploring experience of and engagement in coercive pregnancy behaviors among sexually active young men from five clinics in Baltimore, MD	5
Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception	5
Contextualizing Medicaid reimbursement rates for abortion procedures	5
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)	5
Stakeholder perspectives in New York State on reproductive health and pregnancy intention screening in primary care: A qualitative study	5
Evaluation of a computerized contraceptive decision aid: A randomized controlled trial	5
Abortion for fetal indications: Timing of prenatal diagnosis and abortion for structural and genetic abnormalities	5
An exploratory study comparing the quality of contraceptive counseling provided via telemedicine versus in-person visits	5
Improving assessment of demand for postpartum tubal ligation among publicly insured women in Texas	5
Prioritizing patient experience: Validation of the person-centered contraceptive counseling measure as a performance measure	5
The burden of the Risk Evaluation and Mitigation Strategy (REMS) on providers and patients experiencing early pregnancy loss: A commentary	5
How do women interpret abortion information they find online?	5
Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS)	5
Lessons learned: Illinois providers’ perspectives on implementation of Medicaid coverage for abortion	5
“I'm not going to be a guinea pig:” Medical mistrust as a barrier to male contraception for Black American men in Los Angeles, CA	5
Computer-assisted motivational interviewing for contraceptive use in women leaving prison: A randomized controlled trial	5
Who attends a crisis pregnancy center in Ohio?	5
Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period	5
The next two decades of mifepristone at FDA: History as destiny,	4
Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients	4
Response to requests for contraception in one direct-to-consumer telemedicine service	4
Society of Family Planning Committee statement on IUD nomenclature	4
Variation in effectiveness of planned postpartum contraception at two time points from prenatal to postpartum care	4
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens	4
The integration of abortion into obstetrician-gynecologists’ practice after comprehensive family planning resident training	4
Differences in abortion-related knowledge among women involved in the criminal legal system in three US cities	4
Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist	4
Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial	4
Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example	4
Abortion exceptionalism and the mifepristone REMS	4
Integrating self-managed medication abortion with medical care	4